Last quarter (Q4 2022), Silence Therapeutics's total revenue was $4.76M, an increase of 39.57% from the same quarter last year. In Q4, Silence Therapeutics's net income was $-13.76M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 17.50M	$ 25.38M	$ 17.50M	$ 12.41M	$ 5.48M	$ 244.00K
Cost of Revenue	$ 10.88M	$ 10.32M	$ 10.88M	$ 7.46M	$ 3.76M	$ ―
Gross Profit	$ 6.62M	$ 15.06M	$ 6.62M	$ 4.96M	$ 1.72M	$ 244.00K
Operating Expense	$ 55.21M	$ 64.66M	$ 55.21M	$ 50.77M	$ 34.19M	$ 22.98M
Operating Income	$ -48.59M	$ -49.60M	$ -48.59M	$ -45.81M	$ -32.48M	$ -22.73M
Net Non Operating Interest Income Expense	$ 179.00K	$ 1.41M	$ 179.00K	$ -2.00K	$ -113.00K	$ 6.00K
Other Income Expense	$ ―	$ ―	$ ―	$ -44.00K	$ -3.68M	$ ―
Pretax Income	$ -47.37M	$ -50.31M	$ -47.37M	$ -45.86M	$ -36.04M	$ -22.87M
Tax Provision	$ -6.88M	$ -7.04M	$ -6.88M	$ -6.45M	$ -3.49M	$ -3.29M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -40.49M	$ -43.27M	$ -40.49M	$ -39.41M	$ -32.55M	$ -19.58M
Basic EPS	$ -1.27	$ -0.39	$ -0.42	$ ―	$ -0.40	$ -0.26
Diluted EPS	$ -1.27	$ -0.39	$ -0.42	$ ―	$ -0.40	$ -0.26
Basic Average Shares	$ 128.75M	$ 111.28M	$ 96.58M	$ ―	$ 81.77M	$ 75.13M
Diluted Average Shares	$ 128.75M	$ 111.28M	$ 96.58M	$ ―	$ 81.77M	$ 75.13M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 66.09M	$ 74.98M	$ 66.09M	$ -58.23M	$ -37.95M	$ -22.98M
Net Income From Continuing And Discontinued Operation	$ -40.49M	$ -43.27M	$ -40.49M	$ -39.41M	$ -32.55M	$ -19.58M
Normalized Income	$ -40.49M	$ -57.35M	$ -54.25M	$ -52.30M	$ -39.53M	$ -26.16M
Interest Expense	$ 47.00K	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -47.32M	$ -50.28M	$ -47.32M	$ -45.85M	$ -36.02M	$ -22.84M
EBITDA	$ -46.84M	$ -49.78M	$ -46.84M	$ ―	$ -35.53M	$ -22.36M

Currency in USD

Silence Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing